SCHEMBL6290201

SCHEMBL6290201

CCOC(=O)CCC1(N(C)C(=O)OC(C)(C)C)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
HDAC6 Q9UBN7 2/20 0.33
CYP1A2 P05177 2/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
GAA P10253 2/20 0.32
MGAM O43451 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
POLB P06746 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21257597 0.83 ALDH1A1 (0.34) NFKB1NFKB2RELACYP1A2SMN1; SMN2
SCHEMBL7606626 0.82 HDAC6 (0.33) HDAC6HDAC1HDAC2
SCHEMBL7608850 0.79 ASGR1 (0.35) HDAC6HDAC1HDAC2CYP4F2CYP4A11
SCHEMBL15908023 0.78 CTSD (0.34) NFKB1NFKB2RELAHDAC6HDAC1
SCHEMBL6290954 0.77 CHRNB2 (0.40)
SCHEMBL12209106 0.75 ASGR1 (0.39) NFKB1NFKB2RELAHDAC6HDAC1
SCHEMBL7610203 0.73 ASGR1 (0.33) NFKB1NFKB2RELAHDAC6HDAC1
SCHEMBL29818922 0.73 ASGR1 (0.33) NFKB1NFKB2RELAHDAC6HDAC1
SCHEMBL13010608 0.73 CA14 (0.35) HDAC6HDAC1HDAC2CA12CA1
SCHEMBL4151266 0.73 NFKB1 (0.39) NFKB1NFKB2RELAHDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6943184-B2 1,1- and 1,2-disubstituted cyclopropane compounds LES LABORATORIES SERVIER (FR) 2005-09-13 US disclosed
US-20050032845-A1 1,1-and 1,2-disubstituted cyclopropane compounds GOLDSTEIN SOLO (FR) 2005-02-10 US disclosed
US-20020022643-A1 1,1- and 1,2-disubstituted cyclopropane compounds ADIR ET COMPAGNIE (FR) 2002-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032845-A1 1,1-and 1,2-disubstituted cyclopropane compounds CHRNA1, CHRNA4, CHRNB1 NFKB1 3108/4885NFKB2 2630/4885RELA 3418/4885
US-20020022643-A1 1,1- and 1,2-disubstituted cyclopropane compounds HCAR1, CHRNA1, CNR1 NFKB1 3421/4885NFKB2 3209/4885RELA 3777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.